PL338554A1 - Dipeptidic compounds inhibiting adhesion of leucocytes occurring through the mediation of vla-4 - Google Patents
Dipeptidic compounds inhibiting adhesion of leucocytes occurring through the mediation of vla-4Info
- Publication number
- PL338554A1 PL338554A1 PL98338554A PL33855498A PL338554A1 PL 338554 A1 PL338554 A1 PL 338554A1 PL 98338554 A PL98338554 A PL 98338554A PL 33855498 A PL33855498 A PL 33855498A PL 338554 A1 PL338554 A1 PL 338554A1
- Authority
- PL
- Poland
- Prior art keywords
- dipeptidic
- leucocytes
- vla
- mediation
- occurring
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90441597A | 1997-07-31 | 1997-07-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL338554A1 true PL338554A1 (en) | 2000-11-06 |
Family
ID=25419114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL98338554A PL338554A1 (en) | 1997-07-31 | 1998-07-30 | Dipeptidic compounds inhibiting adhesion of leucocytes occurring through the mediation of vla-4 |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0994895A1 (en) |
JP (1) | JP2001512137A (en) |
KR (1) | KR20010022412A (en) |
CN (1) | CN1265673A (en) |
AR (1) | AR016387A1 (en) |
AU (1) | AU8661298A (en) |
BR (1) | BR9811599A (en) |
CA (1) | CA2291475A1 (en) |
HU (1) | HUP0002682A3 (en) |
IL (1) | IL133642A0 (en) |
NO (1) | NO20000412L (en) |
PL (1) | PL338554A1 (en) |
WO (1) | WO1999006435A1 (en) |
ZA (1) | ZA986834B (en) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6221888B1 (en) | 1997-05-29 | 2001-04-24 | Merck & Co., Inc. | Sulfonamides as cell adhesion inhibitors |
US6903075B1 (en) | 1997-05-29 | 2005-06-07 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
EP0998282A4 (en) * | 1997-05-29 | 2000-08-30 | Merck & Co Inc | Sulfonamides as cell adhesion inhibitors |
WO1998054207A1 (en) * | 1997-05-30 | 1998-12-03 | Celltech Therapeutics Limited | Anti-inflammatory tyrosine derivatives |
DK0991619T3 (en) | 1997-06-23 | 2003-12-29 | Tanabe Seiyaku Co | Inhibitors of alpha 4-beta 1-mediated cell adhesion |
US6455550B1 (en) * | 1997-08-22 | 2002-09-24 | Hoffmann-La Roche Inc. | N-alkanoylphenylalanine derivatives |
MY153569A (en) | 1998-01-20 | 2015-02-27 | Mitsubishi Tanabe Pharma Corp | Inhibitors of ?4 mediated cell adhesion |
US6329372B1 (en) | 1998-01-27 | 2001-12-11 | Celltech Therapeutics Limited | Phenylalanine derivatives |
EP1056714B1 (en) | 1998-02-26 | 2004-08-11 | Celltech Therapeutics Limited | Phenylalanine derivatives as inhibitors of alpha4 integrins |
US6521626B1 (en) | 1998-03-24 | 2003-02-18 | Celltech R&D Limited | Thiocarboxamide derivatives |
GB9811159D0 (en) | 1998-05-22 | 1998-07-22 | Celltech Therapeutics Ltd | Chemical compounds |
GB9811969D0 (en) * | 1998-06-03 | 1998-07-29 | Celltech Therapeutics Ltd | Chemical compounds |
GB9812088D0 (en) * | 1998-06-05 | 1998-08-05 | Celltech Therapeutics Ltd | Chemical compounds |
US6685617B1 (en) | 1998-06-23 | 2004-02-03 | Pharmacia & Upjohn Company | Inhibitors of α4β1 mediated cell adhesion |
GB9814414D0 (en) | 1998-07-03 | 1998-09-02 | Celltech Therapeutics Ltd | Chemical compounds |
US6333340B1 (en) * | 1998-08-14 | 2001-12-25 | Gpi Nil Holdings, Inc. | Small molecule sulfonamides for vision and memory disorders |
US6339101B1 (en) * | 1998-08-14 | 2002-01-15 | Gpi Nil Holdings, Inc. | N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
GB9821061D0 (en) | 1998-09-28 | 1998-11-18 | Celltech Therapeutics Ltd | Chemical compounds |
GB9821222D0 (en) | 1998-09-30 | 1998-11-25 | Celltech Therapeutics Ltd | Chemical compounds |
GB9825652D0 (en) | 1998-11-23 | 1999-01-13 | Celltech Therapeutics Ltd | Chemical compounds |
GB9826174D0 (en) | 1998-11-30 | 1999-01-20 | Celltech Therapeutics Ltd | Chemical compounds |
CZ20012980A3 (en) * | 1999-02-18 | 2002-04-17 | F. Hoffmann-La Roche Ag | Thioamide derivatives |
US6518283B1 (en) | 1999-05-28 | 2003-02-11 | Celltech R&D Limited | Squaric acid derivatives |
JP2003506491A (en) * | 1999-08-13 | 2003-02-18 | バイオジェン インコーポレイテッド | Cell adhesion inhibitor |
EP1214292B1 (en) * | 1999-09-24 | 2007-06-13 | Genentech, Inc. | Tyrosine derivatives |
US6534513B1 (en) | 1999-09-29 | 2003-03-18 | Celltech R&D Limited | Phenylalkanoic acid derivatives |
US6455539B2 (en) | 1999-12-23 | 2002-09-24 | Celltech R&D Limited | Squaric acid derivates |
BR0016818A (en) | 1999-12-28 | 2002-10-01 | Pfizer Prod Inc | Non-peptidyl inhibitors of vla-4-dependent cell adhesion useful in the treatment of inflammatory, autoimmune and respiratory diseases |
ATE375330T1 (en) | 2000-04-17 | 2007-10-15 | Ucb Pharma Sa | ENAMINE DERIVATIVES AS CELL ADHESION MOLECULES |
US6545013B2 (en) | 2000-05-30 | 2003-04-08 | Celltech R&D Limited | 2,7-naphthyridine derivatives |
US6403608B1 (en) | 2000-05-30 | 2002-06-11 | Celltech R&D, Ltd. | 3-Substituted isoquinolin-1-yl derivatives |
US6960597B2 (en) | 2000-06-30 | 2005-11-01 | Orth-Mcneil Pharmaceutical, Inc. | Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists |
WO2002004426A1 (en) | 2000-07-07 | 2002-01-17 | Celltech R & D Limited | Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists |
WO2002008206A1 (en) * | 2000-07-21 | 2002-01-31 | Elan Pharmaceuticals, Inc. | 3-amino-2-(4-aminocarbonyloxy)phenyl-propionic acid derivatives as alpha-4- integrin inhibitors |
EP1305291A1 (en) | 2000-08-02 | 2003-05-02 | Celltech R&D Limited | 3-substituted isoquinolin-1-yl derivatives |
MY129000A (en) | 2000-08-31 | 2007-03-30 | Tanabe Seiyaku Co | INHIBITORS OF a4 MEDIATED CELL ADHESION |
JP2004526733A (en) * | 2001-03-20 | 2004-09-02 | メルク エンド カムパニー インコーポレーテッド | Substituted N-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors |
MY140707A (en) | 2002-02-28 | 2010-01-15 | Mitsubishi Tanabe Pharma Corp | Process for preparing a phenylalanine derivative and intermediates thereof |
WO2005097162A2 (en) * | 2004-04-01 | 2005-10-20 | Elan Pharmaceuticals, Inc. | Steroid sparing agents and their use |
AU2008219007A1 (en) | 2007-02-20 | 2008-08-28 | Merrimack Pharmaceuticals, Inc. | Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist |
CA2721093A1 (en) | 2008-04-11 | 2009-10-15 | Merrimack Pharmaceuticals, Inc. | Human serum albumin linkers and conjugates thereof |
EP2774919A1 (en) * | 2013-03-06 | 2014-09-10 | Pharmeste S.R.L. In Liquidazione | Novel sulfonamide TRPA1 receptor antagonists |
WO2014142255A1 (en) | 2013-03-14 | 2014-09-18 | 武田薬品工業株式会社 | Heterocyclic compound |
WO2015002231A1 (en) * | 2013-07-03 | 2015-01-08 | 武田薬品工業株式会社 | Heterocyclic compound |
EP3018123B1 (en) | 2013-07-03 | 2023-05-10 | Takeda Pharmaceutical Company Limited | Amide compound |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU693143B2 (en) * | 1993-12-06 | 1998-06-25 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using the same |
US6306840B1 (en) * | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
-
1998
- 1998-07-30 BR BR9811599-5A patent/BR9811599A/en not_active Application Discontinuation
- 1998-07-30 JP JP2000505190A patent/JP2001512137A/en not_active Withdrawn
- 1998-07-30 ZA ZA9806834A patent/ZA986834B/en unknown
- 1998-07-30 EP EP98937991A patent/EP0994895A1/en not_active Withdrawn
- 1998-07-30 PL PL98338554A patent/PL338554A1/en unknown
- 1998-07-30 AU AU86612/98A patent/AU8661298A/en not_active Abandoned
- 1998-07-30 KR KR1020007000992A patent/KR20010022412A/en not_active Application Discontinuation
- 1998-07-30 AR ARP980103776A patent/AR016387A1/en unknown
- 1998-07-30 CN CN98807762A patent/CN1265673A/en active Pending
- 1998-07-30 WO PCT/US1998/015314 patent/WO1999006435A1/en not_active Application Discontinuation
- 1998-07-30 HU HU0002682A patent/HUP0002682A3/en unknown
- 1998-07-30 IL IL13364298A patent/IL133642A0/en unknown
- 1998-07-30 CA CA002291475A patent/CA2291475A1/en not_active Abandoned
-
2000
- 2000-01-27 NO NO20000412A patent/NO20000412L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0994895A1 (en) | 2000-04-26 |
NO20000412L (en) | 2000-03-24 |
KR20010022412A (en) | 2001-03-15 |
IL133642A0 (en) | 2001-04-30 |
CA2291475A1 (en) | 1999-02-11 |
WO1999006435A1 (en) | 1999-02-11 |
BR9811599A (en) | 2000-09-19 |
CN1265673A (en) | 2000-09-06 |
HUP0002682A3 (en) | 2001-12-28 |
AU8661298A (en) | 1999-02-22 |
NO20000412D0 (en) | 2000-01-27 |
AR016387A1 (en) | 2001-07-04 |
JP2001512137A (en) | 2001-08-21 |
HUP0002682A1 (en) | 2001-07-30 |
ZA986834B (en) | 2000-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL338554A1 (en) | Dipeptidic compounds inhibiting adhesion of leucocytes occurring through the mediation of vla-4 | |
PL338521A1 (en) | Carbamyloxylic compounds inhibiting adhesion of leucocytes occurring through the mediation of vla-4 | |
PL338506A1 (en) | Compounds inhibiting adhesion of leucocytes occuring through the mediation of vla-4 | |
PL338510A1 (en) | Benzyl compounds inhinbiting the adhesion of leucocytes occurring through the mediation of vla-4 | |
PL338457A1 (en) | Sulphonylated dipeptidic compounds capable to inhibit adhesion of leucocytes through the mediation of vla-4 | |
PL338373A1 (en) | Dipeptide and its affinite compounds inhibiting adhesion of leucocytes occurring through mediation of vla-4 | |
PL338413A1 (en) | Compound of 4-amino phenylalanine type inhibiting adhesion of leucocytes through the meditation of vla-4 | |
PL338423A1 (en) | Compounds of substituted phenylamine type capable to inhibit adhesion of leucocytes through the mediation of vla-4 | |
IL127563A0 (en) | Cell adhesion inhibiting compounds | |
HUP0104766A3 (en) | Aza-bicycles which modulate the inhibition of cell adhesion and medicaments containing them | |
EG22340A (en) | A suit for protection against the effects of acceleration | |
AU8547198A (en) | Pyridyl- and pyrimidyl-heterocyclic compounds inhibiting oxido squalene-cyclase | |
GB2341180A9 (en) | Compounds on the basis of polyalkyl-1-oxa diazaspirodecane compounds | |
GB9725434D0 (en) | Sputter deposition | |
GB9706294D0 (en) | Heterocyclic compound | |
EP1028947B8 (en) | H3 receptor ligands of the phenyl-alkyl-imidazoles type | |
GB9717498D0 (en) | Substrate facing | |
GB9711118D0 (en) | Compound | |
GB9522007D0 (en) | New compound | |
GR3029513T3 (en) | Peptides inhibiting the release of pepsine | |
GB9501676D0 (en) | Record protection tab | |
TW361512U (en) | Improved structure for the sealing buckle | |
PL320282A1 (en) | Film riding face seal | |
TW371849U (en) | Improved structure for the hang tag of sealing type | |
HU9602535D0 (en) | Peptides inhibiting the release of pepsine |